Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk
Cardiovascular Risk Factors
Clinical Practice Guideline
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Health Services Research
|Official Title:||Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk.|
|Study Start Date:||January 2004|
|Study Completion Date:||July 2010|
|Primary Completion Date:||April 2006 (Final data collection date for primary outcome measure)|
|Experimental: Implementation||Other: Implementation|
|Active Comparator: dissemination||Other: dissemination|
With this objective this study will be developed in three diferent phases. The guideline in clinical practice elaboration. It will be based in evidence medicine and it will be adapted based in the cardiovascular risk factors guidelines published at the present.
The spreding and implementation of the guideline between the sanitarians, as much in primary medicine as in specialised area, involved in the care of the patient in cardiovascular risk, in the Area 2 in Madrid.
And the evaluation of the implementation strategy, used between the primary care physicians.
For the local adaptation, will be used a systematic review of the different guidelines in the Spanish and international literature, published in the last years about this topic.
The ones with better quality criteria will be selected and doctors and nurses related from different specialities, involved in the cardiovascular illness, as much as members of the staff of the medical management an nursery, will be invited to participate in the selection of the recommendations of the guides and in the search of the consensus. After that, this guide will be given to a group of patients, who will be asked for a critical approach and their suggestions will be applied.
The evaluation will be done with a clinical trial designe , testing the use of the guide and its results on health intermediary variables. With this objective the results with an implementation technique based on opinion leaders plus computer reminder, will be evaluated, instead of using the standard implementation.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01270022
|Gerencia de Atención Primaria del área 2|
|Madrid, Spain, 28009|
|Principal Investigator:||Blanca Novella, MD. pHD||Gerencia de Atención Primaria del área 2|